Cornea

Early diagnosis of keratoconus is vital given the disease's prevalence in pediatric patient, according to Jennifer Harthan, OD, FAAO, FSLS.

Shelley Cutler, OD, FAAO, comments on technological advancements leading to the progression of keratoconus diagnosis and treatment options during this year's IKA symposium.

Melissa Barnett, OD, Director of Optometry at the University of California, Davis, talked about her session at IKA that focused on keratoconus from the patient perspective.

Justin Schweitzer, OD, FAAO, from Vance Thompson Vision, talked about his session at the IKA Symposium that discussed cross-linking in keratoconus treatment both now and looking toward the future.

Barry Eiden, OD, FAAO, FSLS, President and Co-founder of IKA, talked about his session at the meeting centering around the pediatric prevalence of keratoconus, the importance of early diagnosis, and the impact this can have on practices.

The collective enhances education, research, and quality of life.

The IOL launch is the company’s second market debut in less than 12 months.

What axial length readings and crystalline lens power tell you.

Pterygium is an ocular disease commonly referred to as “surfer’s eye,” which can result from exposure to high levels of UV radiation.

The study authors also noted that patients responding well to routine intense pulsed light sessions do not need to undergo additional sessions.

The 1-time, intracameral injection is a cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction.

Shifting the treatment paradigm can lead to less pain, inflammation

Ferroptosis is a form of cell death that depends on the presence of iron in the cells.

Oluwatosin U Smith, MD, urges consideration of the interaction between corneal and glaucomatous disease whenever treating glaucoma or corneal issues during the annual Glaucoma 360 meeting in San Francisco, California.

OKYO Pharma announced the acceptance of OK-101 as an investigational new drug following clinical studies investigating the candidate in patients with neuropathic corneal pain, the first to do so.

The study, based out of India, successfully transplanted 32 of 34 corneas harvested from drowning victims.

Much has changed in the study of keratoconus over the years.

Earlier this year, Aurion’s cell therapy received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency for the management of bullous keratopathy, marking the first regulatory approval in the world for an allogeneic cell therapy to manage corneal endothelial disease.

Hear how the Clek study continues to play a role in today's keratoconus care.

Private practice eye care providers’ ability to immediately administer antibiotic eye drops or have them overnighted to the patient is a giant step forward for practice and patient.

The ‘all-in-one’ platform combines specialized imaging and three new FDA-approved apps with a focus on metrics, corneal imaging, and cataract care.

Combination therapy may reduce adverse events related to corticosteroids alone.

In this part 2 of the pediatric myopia and keratoconus series, Drs Chan and Swartz dive into ortho-k and crosslinking in children.

Treatment requires a systematic, multifaceted approach to improve outcomes.